Bridging the Gap: Integrating Behavioral Health into Primary Care __________________________________
• Significant weight loss when not dieting or weight gain: This can also manifest as decreased or increased appetite. • Insomnia or hypersomnia nearly every day: Difficulty falling asleep and staying asleep or sleeping excessively. • Psychomotor agitation or retardation nearly every day: Restlessness or slowed movements observable by others. • Fatigue or loss of energy nearly every day: Feeling tired and lacking motivation. • Feelings of worthlessness or excessive or inappropriate guilt nearly every day: This can involve self-blame and negative self-perception. • Diminished ability to think or concentrate, or indecisiveness, nearly every day: Difficulty with focus, decision-making, and memory. • Recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt or a specific plan for committing suicide: These thoughts can range from passive thoughts of death to active suicidal ideation. It is important to note that these symptoms must cause clini- cally significant distress or impairment in social, occupational, or other important areas of functioning. Additionally, the symptoms cannot be attributable to the physiological effects of a substance (e.g., drug abuse, medication) or another medical condition (e.g., hypothyroidism). The clinical presentation of depression can vary significantly from person to person. Some individuals may exhibit predominantly emotional symptoms, while others may experience more physical symptoms. The severity of symptoms can also range from mild to severe, with some individuals experiencing psychotic features such as delusions or hallucinations. SCREENING TOOLS Early detection and diagnosis of depression are crucial for effective treatment (Bienenfeld, 2024). Several screening tools are available to help identify individuals who may be experi- encing depression: • PHQ-2 (Patient Health Questionnaire-2): This brief two-item screening tool asks about the frequency of depressed mood and anhedonia (loss of interest or pleasure) over the past two weeks. A positive PHQ-2 often warrants further evaluation with a more comprehensive tool like the PHQ-9. • PHQ-9 (Patient Health Questionnaire-9): This is a nine-item screening tool that assesses the severity of depression symptoms based on DSM-5 criteria. Each item is scored on a scale of 0 to 3, with higher scores indicating greater severity. The PHQ-9 can also be used to monitor treatment response.
These screening tools are valuable for primary care settings and other healthcare environments to identify individuals who may benefit from further evaluation and treatment for depression. Evidence-Based Treatments Evidence-based treatments for depression primarily include psychotherapy and medication (Karrouri et al., 2021): • Psychotherapy: Several types of psychotherapy have proven effective for depression, including the following: ‒ Cognitive behavioral therapy (CBT): This therapy focuses on identifying and changing negative thought patterns and behaviors that contribute to depression. ‒ Interpersonal therapy (IPT): This therapy addresses interpersonal difficulties and relationship issues that may be contributing to depression. ‒ Psychodynamic therapy: This therapy
explores past experiences and unconscious processes that may influence current mood and behavior.
• Medication: Antidepressant medications are often used in conjunction with psychotherapy or as a standalone treatment for moderate to severe depression. Several classes of antidepressants are available, including: ‒ Selective serotonin reuptake inhibitors (SSRIs): These medications increase serotonin levels in the brain, which can improve mood and reduce anxiety. ‒ Serotonin-norepinephrine reuptake inhibitors (SNRIs): These medications increase serotonin and norepinephrine levels in the brain. ‒ Tricyclic antidepressants (TCAs): These older antidepressants are effective but can have more side effects than newer medications. ‒ Monoamine oxidase inhibitors (MAOIs): These medications are less commonly used due to potential interactions with certain foods and medications. The choice of treatment depends on individual factors such as the severity of depression, patient preferences, and the presence of co-occurring conditions. Often, a combination of psychotherapy and medication is most effective. Management of Treatment-Resistant Depression Treatment-resistant depression refers to depression that does not respond adequately to initial treatments (Karrouri et al., 2021). Managing treatment-resistant depression often requires a multifaceted approach, including:
144
EliteLearning.com/Psychology
Powered by FlippingBook